Sport status / C-033
Experimental peptides, athletes and the WADA Prohibited List
A failed name search is not clearance. Peptides can be prohibited by explicit name, class wording or a catch-all for similar substances.
The 2026 WADA Prohibited List has been in force since 1 January 2026. It prohibits several peptide hormones, growth factors, related substances and mimetics, alongside other classes that can capture peptide-related compounds. Not every substance is named, so an exact-name search alone cannot establish permission.
UK Anti-Doping states that an athlete is responsible for any prohibited substance found in their system, regardless of how it arrived or whether there was intent to cheat.
Four possible outcomes from a List check
| Outcome | Meaning | Next action |
|---|---|---|
| Explicit match | The exact substance or a clear synonym appears. | Record the section and whether prohibition applies at all times or in competition. |
| Class or catch-all match | The substance fits class wording or similar-structure or similar-effect language. | Do not rely on the missing exact name. Seek anti-doping guidance if interpretation is uncertain. |
| Uncertain identity | The label, alias or actual vial contents are not reliable enough for classification. | Treat the product uncertainty as an anti-doping risk as well as a health risk. |
| Not located | No exact or class match was identified in the check performed. | Record the search terms, List version and date. This is not a guarantee of permission. |
The vial creates a second anti-doping question
Status of the named substance
Check the exact identity, synonyms and relevant class against the current List. An authorised medicine can also require a Therapeutic Use Exemption under the applicable rules.
Status of what is actually present
An unverified product may contain an undeclared substance or a different amount. Under strict liability, a seller's label or assurance is not a defence for presence or use.
Read strict liability and exemptions before relying on a medicine authorisation or seller statement.
Run a defensible check
Follow the step-by-step method to check a substance against the WADA List, including aliases, class wording, effective date and a written record of the result.
How we state sport status
Every compound record states the List year, access date and match type: explicit, class or catch-all, uncertain, or not located. We do not use “not found” as a green status. We do not publish detection windows or evasion guidance.
Peptide and anti-doping questions
Are all peptides banned in sport?
No. Peptide is a chemical description, not one anti-doping category. Some substances are named, some fall within a prohibited class or catch-all clause, and others require further checking. Use the current List and exact substance identity.
Does a nil name search mean a peptide is permitted?
No. WADA and UK Anti-Doping explain that not every prohibited substance is named. Similar chemical structures or biological effects can fall within class wording.
Does accidental contamination protect an athlete from a violation?
Strict liability means an athlete is responsible for prohibited substances found in their system regardless of intent. Contamination may affect case assessment, but supplier assurances or an incomplete label are not a clearance.
How often does the WADA List change?
WADA publishes a new List each year, normally effective on 1 January, and can make changes during the year with notice. Record the List version and date whenever you check a substance.
Primary anti-doping sources
- WADA 2026 Prohibited ListAccessed 7 August 2026
- WADA: 2026 List in forceAccessed 7 August 2026
- UK Anti-Doping: what is bannedAccessed 7 August 2026
- UK Anti-Doping: athlete responsibilitiesAccessed 7 August 2026
- the annual sport list changesSources checked 9 August 2026
Editorial experience
From our work: how we checked this page
For topical-map item C-033, Experimental peptides, athletes and the WADA Prohibited List was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 4 unique external sources and 7 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Yianni Kiromitis checked the page against its mapped purpose, verified the cited sources, reviewed the internal routes and approved the final wording as Lead Author, Publisher and Managing Editor. This page does not carry a specialist review credit because its publication decision did not require a scientific or clinical conclusion beyond the named material it links to.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.